The summary below is from the full report titled “Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women.” It is in the 3 May 2005 issue of Annals of Internal Medicine (volume 142, pages 734-741). The authors are J.T. Schousboe, J.A. Nyman, R.L. Kane, and K.E. Ensrud.
Cost-Effectiveness of Alendronate in Postmenopausal Women with Low Bone Mass without Osteoporosis or Previous Fracture. Ann Intern Med. 2005;142:I–36. doi: https://doi.org/10.7326/0003-4819-142-9-200505030-00002
Download citation file:
Published: Ann Intern Med. 2005;142(9):I-36.
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use